After Glaxo, Six Questions Your Compliance Team Needs To Ask
July 26, 2013
Chinese officials are investigating what they say is an on-going multimillion dollar pattern of bribery by GlaxoSmithKline. Based on what’s being alleged, there are already some clear lessons for companies and their overseas risk management compliance teams. Here is a short list, in the form of six questions designed to ferret out corruption.
Read full article at:
Daily Updates
Sign up for our free daily newsletter for the latest news and business legal developments.